| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |